de LeonJRuanCJSchoretsanitisG, et al. (2024) Investigating in VigiBase over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: Focus on high lethality and the association with aspiration pneumonia. Expert Opinion on Drug Metabolism & Toxicology20: 857–871.
2.
LuykxJJCorrellCUManuP, et al. (2024) Pneumonia risk, antipsychotic dosing, and anticholinergic burden in schizophrenia. Journal of the American Medical Association Psychiatry81: 967–975.
3.
NersesjanVChristensenRHBAndersenEW, et al. (2024) Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders during the COVID-19 pandemic: A Danish nationwide registry study. The Lancet Psychiatry11: 796–806.
4.
PollmächerTHaackMSchuldA, et al. (2000) Effects of antipsychotic drugs on cytokine networks. Journal of Psychiatric Research34: 369–382.
5.
SeminogOOGoldacreMJ (2013) Risk of pneumonia and pneumococcal disease in people with severe mental illness: English record linkage studies. Thorax68: 171–176.
